These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5897487)

  • 41. [Echodiagnosis of the kidney lesion in gout].
    Tsurko VV; Zeĭdlits LA; Akimova TF; Novoselova TM; Altunina AN
    Ter Arkh; 1986; 58(8):35-7. PubMed ID: 3532410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Malignant course of gout nephropathy with findings of an atypical amyloid].
    Hrncír Z; Jindrák K
    Vnitr Lek; 1965 Jul; 11(7):673-8. PubMed ID: 5835575
    [No Abstract]   [Full Text] [Related]  

  • 43. Uric acid nephropathy and end-stage renal disease--review of a non-disease.
    Nickeleit V; Mihatsch MJ
    Nephrol Dial Transplant; 1997 Sep; 12(9):1832-8. PubMed ID: 9306331
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 45. [Features differentiating between gout and asymptomatic hyperuricemias (1). Clinical study].
    Bueno Jiménez C; Gil Micharet MS; Grau Linares V; Pérez Miranda M
    Rev Clin Esp; 1983 Sep; 170(5):199-203. PubMed ID: 6647941
    [No Abstract]   [Full Text] [Related]  

  • 46. Editorial: The "gouty" kidney.
    Shugh KS
    J Assoc Physicians India; 1973 Oct; 21(10):883-4. PubMed ID: 4793278
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hyperuricemia, gout and gout-induced nephropathy].
    Arkhipov VE; Borisov IA; Nasonov EL; Sura VV
    Ter Arkh; 1980; 52(4):133-42. PubMed ID: 6996182
    [No Abstract]   [Full Text] [Related]  

  • 48. Altered uric acid levels and disease states.
    Kutzing MK; Firestein BL
    J Pharmacol Exp Ther; 2008 Jan; 324(1):1-7. PubMed ID: 17890445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gout and cardiovascular disease.
    Winocour PD; Turner MR; Taylor TG; Munday KA
    Lancet; 1977 Apr; 1(8018):959-60. PubMed ID: 67424
    [No Abstract]   [Full Text] [Related]  

  • 50. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study.
    Lin KC; Lin HY; Chou P
    J Rheumatol; 2000 Jun; 27(6):1501-5. PubMed ID: 10852278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Kidney function in gout patients based on N-acetyl-beta-D glucosaminidase, human serum albumin and beta-2 microglobulin levels].
    Poór G; Jósfay L; Falus A; Mituszova M
    Orv Hetil; 1981 Aug; 122(33):2012-4. PubMed ID: 7031559
    [No Abstract]   [Full Text] [Related]  

  • 52. [Diabetic and gouty nephropathies (certain aspects)].
    Sura VV; Borisov IA; Kamaeva OI; Filippova VG
    Ter Arkh; 1995; 67(8):3-5. PubMed ID: 7482328
    [No Abstract]   [Full Text] [Related]  

  • 53. [Gout: current views. Stage oriented treatment].
    Fedorova NE; Grigor'eva VD
    Klin Med (Mosk); 2002; 80(2):9-13. PubMed ID: 11898731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship between gout and the kidney.
    WALLACE SL; BERNSTEIN D
    Metabolism; 1963 May; 12():440-6. PubMed ID: 13998565
    [No Abstract]   [Full Text] [Related]  

  • 55. [Anatomoclinical observations on a case of plurivisceral gout].
    Martuzzi M; Morgagni W; Piredda A; Saragoni A
    Pathologica; 1968; 60(887):279-99. PubMed ID: 5729084
    [No Abstract]   [Full Text] [Related]  

  • 56. [Visceral manifestations of gout].
    Tacquet A
    Lille Med; 1970 Jan; 15(1):250-3. PubMed ID: 5440979
    [No Abstract]   [Full Text] [Related]  

  • 57. Azapropazone or allopurinol in the treatment of chronic gout and/or hyperuricaemia. A preliminary report.
    Templeton JS
    Br J Clin Pract; 1982 Oct; 36(10):353-8. PubMed ID: 7171423
    [No Abstract]   [Full Text] [Related]  

  • 58. Eye tophi deposition in gout.
    Martínez-Cordero E; Barreira-Mercado E; Katona G
    J Rheumatol; 1986 Apr; 13(2):471-3. PubMed ID: 3723515
    [No Abstract]   [Full Text] [Related]  

  • 59. [Familial juvenile gouty nephropathy].
    Okabe H; Hosoya T; Sakai O
    Ryoikibetsu Shokogun Shirizu; 1997; (17 Pt 2):266-8. PubMed ID: 9277913
    [No Abstract]   [Full Text] [Related]  

  • 60. [Urine fibrinolytic activity as an indicator of kidney damage in uric acid metabolic imbalance].
    Shcherbak AV; Balkarov IM; Kozlovskaia LV; Podorol'skaia LV; Gindis AA
    Ter Arkh; 2001; 73(6):34-7. PubMed ID: 11521518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.